Senior insider sale
Chief Operating Officer at X4 PHARMACEUTICALS, INC — senior position signals high conviction
$7.7K
4.82K shares
What this filing means
DIBIASE MARY plans to sell 4.82K shares of X4 PHARMACEUTICALS, INC valued at approximately $7.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/8/2023ACC: 0001973141-23-000210
Officer· Chief Operating Officer
Since Sep 2021
4.82K
Shares to sell
$7.7K
Approx. market value
2.64K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Award
N/A
9/8/2023
2.64KTotal acquired2.64K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/8/2023 | Stock Award N/A | 2.64K | — |
| Total | 2.64K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
464.00
Market value
$878.31
6/30/2023
—Completed
Units to sell
857.00
Market value
$1.7K
6/23/2023
—Completed
Units to sell
857.00
Market value
$1.9K
6/15/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.64K
Market value
$3.3K
9/8/2023
Total
Units
4.82K
Value
$7.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2023 | 464.00 | $878.31 | — | Completed |
6/23/2023 | 857.00 | $1.7K | — | Completed |
6/15/2023 | 857.00 | $1.9K | — | Completed |
| Planned — Approximate Date | ||||
9/8/2023 | 2.64K | $3.3K | NASDAQ | Planned |
| Total | 4.82K | $7.7K | ||